Epilepsy drug study to focus on elderly patients
December 1, 1997 less than 1 minute read
Epilepsy drug study to focus on elderly patients
The Pharmacy Corporation of America (PCA), a private for-profit business, is embarking on an ambitious study of 67,000 nursing home patients suffering from epilepsy. Funded largely by a grant from the National Institutes of Health (NIH), the program is being run as a shared-database undertaking by PCA and researchers at the University of Minnesota, aimed at studying dosing regimens, toxicity and diagnostic factors in epilepsy use. The study hopes to determine the best ways for elderly patients to experience fewer seizures while minimizing the side effects of epilepsy drugs. It is part of the five-year Epilepsy Clinic Research Program under the auspices of the NIH.
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content